Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes.

Leukemia & lymphoma - 1 Jun 2018

Raess Philipp W, Moore Stephen R, Cascio Michael J, Dunlap Jennifer, Fan Guang, Gatter Ken, Olson Susan B, Braziel Rita M

Abstract excerpt

Accurate subclassification of aggressive B cell lymphomas (ABCLs) requires integration of morphologic, immunohistochemical (IHC), and cytogenetic information. Optimal strategies have not been well defined for diagnosis of high grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements (HGBLwR) and double expressor lymphomas with MYC and BCL2 protein overexpression. One hundred and eighty seven ABCLs were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytogenetic Analysis
Share to In Situ Hybridization, Fluorescence

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Ki-67 Antigen

Share to Lymphoma, B-Cell

Share to Neoplasm Grading

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins c-myc

Share to Reproducibility of Results

Source

Identifiers

PMID: 28868942
DOI: 10.1080/10428194.2017.1370547

Genes

MYC
BCL2
BCL6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes.PMID 28868942Read ↗

Further Exploration of the Complexities of Large B-Cell Lymphomas With MYC Abnormalities and the Importance of a Blastoid MorphologySemantic proximity Read ↗

Advances in pathological understanding of high-grade B cell lymphomas.Semantic proximity Read ↗

Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.Semantic proximity Read ↗

Aggressive B-cell lymphomas—from morphology to molecular pathogenesisSemantic proximity Read ↗

Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classificationSemantic proximity Read ↗

Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.Semantic proximity Read ↗

The high-grade B-cell lymphomas: double hit and moreSemantic proximity Read ↗

High-grade B-cell lymphoma: a term re-purposed in the revised WHO classification.Semantic proximity Read ↗

MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.Semantic proximity Read ↗

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapySemantic proximity Read ↗

Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organisation's 2017 classification.Semantic proximity Read ↗

Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangementsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.